Supernus Pharmaceuticals Inc SUPN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/17/21 EDT
27.28UNCH (UNCH)
Volume
76,034
Close
27.28quote price arrow up+0.09 (+0.33%)
Volume
850,613
52 week range
17.20 - 34.29
Loading...
  • Open27.24
  • Day High27.46
  • Day Low26.51
  • Prev Close27.19
  • 52 Week High34.29
  • 52 Week High Date06/16/21
  • 52 Week Low17.20
  • 52 Week Low Date10/29/20

Key Stats

  • Market Cap1.45B
  • Shares Out53.15M
  • 10 Day Average Volume0.33M
  • Dividend-
  • Dividend Yield-
  • Beta1.25
  • YTD % Change8.43

KEY STATS

  • Open27.24
  • Day High27.46
  • Day Low26.51
  • Prev Close27.19
  • 52 Week High34.29
  • 52 Week High Date06/16/21
  • 52 Week Low17.20
  • 52 Week Low Date10/29/20
  • Market Cap1.45B
  • Shares Out53.15M
  • 10 Day Average Volume0.33M
  • Dividend-
  • Dividend Yield-
  • Beta1.25
  • YTD % Change8.43

RATIOS/PROFITABILITY

  • EPS (TTM)1.85
  • P/E (TTM)14.71
  • Fwd P/E (NTM)24.34
  • EBITDA (MRQ)175.785M
  • ROE (MRQ)13.80%
  • Revenue (MRQ)570.95M
  • Gross Margin (MRQ)86.01%
  • Net Margin (MRQ)17.55%
  • Debt To Equity (MRQ)47.15%

EVENTS

  • Earnings Date11/01/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Supernus Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
Supernus Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. The Company offers Oxtellar XR (extended-release oxcarbazepine) and Trokendi XR (extended-release topiramate), its two treatments for patients with epilepsy. In addition, it is developing multiple product candidates in psychiatry to address unmet medical needs and market opportunities for the treatment of impulsive...
Charles Newhall III
Chairman
Jack Khattar
President
Timothy Dec CPA
Chief Financial Officer
Address
9715 Key West Avenue
Rockville, MD
20850
United States

Top Peers

SYMBOLLASTCHG%CHG
AMRN
Amarin Corporation PLC
5.15-0.02-0.39%
INVA
Innoviva Inc
15.65+0.41+2.69%
IRWD
Ironwood Pharmaceuticals Inc
12.35+0.27+2.24%
TVTX
Travere Therapeutics Inc
22.51+0.07+0.31%
AMPH
Amphastar Pharmaceuticals Inc
18.37+0.44+2.45%